Search research articles
Contact Us
Filters
Showing results (1-10 of 6) with videos related to
Page
of 1
Sort By:
Journal of Allied Health
|
March 4, 2017
A Novel and Cost-Effective Method for Evaluating Cardiopulmonary Auscultation Skills in Student Physical Therapists
David O Sword, K Jackson Thomas, Holly H Wise, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 8, 2008
HIV seroconversion without infection after receipt of adenovirus-vectored HIV type 1 vaccine
Erin K Quirk, Robin Mogg, Deborah D Brown, et al.
Journal of Viral Hepatitis
|
June 29, 2020
Safety and tolerability of elbasvir/grazoprevir in chronic hepatitis C virus therapy: Integrated analysis from clinical trials
Gayatri Nangia, John M Vierling, Paul Kwo, et al.
Current HIV Research
|
January 5, 2011
Long-term safety from the raltegravir clinical development program
Hedy Teppler, Deborah D Brown, Randi Y Leavitt, et al.
Annals of Internal Medicine
|
April 25, 2015
Grazoprevir-Elbasvir Combination Therapy for Treatment-Naive Cirrhotic and Noncirrhotic Patients With Chronic Hepatitis C Virus Genotype 1, 4, or 6 Infection: A Randomized Trial
Stefan Zeuzem, Reem Ghalib, K Rajender Reddy, et al.
Ebiomedicine
|
January 18, 2022
Safety and immunogenicity of the measles vector-based SARS-CoV-2 vaccine candidate, V591, in adults: results from a phase 1/2 randomised, double-blind, placebo-controlled, dose-ranging trial
Frédéric Vanhoutte, Wen Liu, Richard T Wiedmann, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 6) with videos related to
Sort By:
Page
of 1
Journal of Allied Health
|
March 4, 2017
A Novel and Cost-Effective Method for Evaluating Cardiopulmonary Auscultation Skills in Student Physical Therapists
David O Sword, K Jackson Thomas, Holly H Wise, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 8, 2008
HIV seroconversion without infection after receipt of adenovirus-vectored HIV type 1 vaccine
Erin K Quirk, Robin Mogg, Deborah D Brown, et al.
Journal of Viral Hepatitis
|
June 29, 2020
Safety and tolerability of elbasvir/grazoprevir in chronic hepatitis C virus therapy: Integrated analysis from clinical trials
Gayatri Nangia, John M Vierling, Paul Kwo, et al.
Current HIV Research
|
January 5, 2011
Long-term safety from the raltegravir clinical development program
Hedy Teppler, Deborah D Brown, Randi Y Leavitt, et al.
Annals of Internal Medicine
|
April 25, 2015
Grazoprevir-Elbasvir Combination Therapy for Treatment-Naive Cirrhotic and Noncirrhotic Patients With Chronic Hepatitis C Virus Genotype 1, 4, or 6 Infection: A Randomized Trial
Stefan Zeuzem, Reem Ghalib, K Rajender Reddy, et al.
Ebiomedicine
|
January 18, 2022
Safety and immunogenicity of the measles vector-based SARS-CoV-2 vaccine candidate, V591, in adults: results from a phase 1/2 randomised, double-blind, placebo-controlled, dose-ranging trial
Frédéric Vanhoutte, Wen Liu, Richard T Wiedmann, et al.
Page
of 1